Breast Cancer Canada at CDA Symposium

Last week, Breast Cancer Canada had the privilege of participating in the Canada’s Drug Agency (CDA) Symposium 2024, held both in-person at the Ottawa Shaw Centre and virtually. The event, themed “From Disruption to Opportunity: Embracing Change in Health Care,” brought together a diverse group of leaders from policy, industry, health technology assessment, patient advocacy, […]